gruenberger

KNSA Ascending Triangle and PDUFA

做多
gruenberger 已更新   
NASDAQ:KNSA   Kiniksa Pharmaceuticals, Ltd.
Updated ascending trend line. General thesis still holding.
评论:
Approval
评论:
...aaaand PDUFAs are no longer valuable catalysts. ENTX was a phase 2 data announcement, perhaps that is a better catalyst.

Welp, lesson learned. love learning lessons. /s
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。